Gut Microbiomes Alterations in Obesity: A Review of Pathophysiological Mechanism and Therapeutic Interventions

The bacterial cells in the human gastrointestinal tract (GIT) outweigh the host cells by a factor of ten, and the genes encoded by the bacteria in the GIT outnumber their host genes by more than a hundredfold. The gut microbiome refers to the bacteria associated with the human digestive tract. The human gut microbiome and its role in health and disease have been extensively studied, with findings indicating participation in human metabolism, nutrition, physiology, and immunological function. Imbalances in the normal gut microbiota have been related to gastrointestinal disorders such as inflammatory bowel disease, type 2 diabetes, and atopy. In the first part of this review, we evaluate our evolving knowledge of the composition, pathophysiological mechanism, and Regulation of Appetite, and the ways in which the microbial community is perturbed in dysbiotic disease states; the second part of this review covers the role of interventions that have been shown to modulate and stabilize the gut microbiota, as well as restore it to its healthy composition from the dysbiotic states seen in IBS, IBD, obesity, type 2 diabetes.

Gut Microbiomes, Inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Immunological function

1. Tseng CH, Wu CY. The gut microbiome in obesity. J Formos Med Assoc. 2019 Mar;118 Suppl 1:S3-S9. doi: 10.1016/j.jfma.2018.07.009. Epub 2018 Jul 26. PMID: 30057153. [Google Scholar] [Crossref]

2. Gill VJS, Soni S, Shringarpure M, Anusheel, Bhardwaj S, Yadav NK, Patel A, Patel A. Gut Microbiota Interventions for the Management of Obesity: A Literature Review. Cureus. 2022 Sep 19;14(9):e29317. doi: 10.7759/cureus.29317. PMID: 36161997; PMCID: PMC9484223. [Google Scholar] [Crossref]

3. Fan S, Chen S, Lin L. Research progress of gut microbiota and obesity caused by high-fat diet. Front Cell Infect Microbiol. 2023 Mar 13;13:1139800. doi: 10.3389/fcimb.2023.1139800. PMID: 36992691; PMCID: PMC10040832. [Google Scholar] [Crossref]

4. Sasidharan Pillai S, Gagnon CA, Foster C, Ashraf AP. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes. J Clin Endocrinol Metab. 2024 Oct 15;109(11):2709-2719. doi: 10.1210/clinem/dgae499. PMID: 39040013; PMCID: PMC11479700. [Google Scholar] [Crossref]

5. Odamaki, T., Kato, K., Sugahara, H. et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16, 90 (2016). [Google Scholar] [Crossref]

6. https://doi.org/10.1186/s12866-016-0708-5. [Google Scholar] [Crossref]

7. Cunningham AL, Stephens JW, Harris DA. A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis. 2021 Jul 7;20(1):65. doi: 10.1186/s12944-021-01491-z. PMID: 34233682; PMCID: PMC8262044. [Google Scholar] [Crossref]

8. Hardin BI, Keyes D. Enterohormonal and Microbiota Pathophysiology of Obesity. 2024 Dec 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 35201732. [Google Scholar] [Crossref]

9. Fan S, Chen S, Lin L. Research progress of gut microbiota and obesity caused by high-fat diet. Front Cell Infect Microbiol. 2023 Mar 13;13:1139800. doi: 10.3389/fcimb.2023.1139800. PMID: 36992691; PMCID: PMC10040832. [Google Scholar] [Crossref]

10. Nemoto S, Kubota T, Ohno H. Exploring body weight-influencing gut microbiota by elucidating the association with diet and host gene expression. Sci Rep. 2023 Apr 5;13(1):5593. doi: 10.1038/s41598-023-32411-z. PMID: 37019989; PMCID: PMC10076326. [Google Scholar] [Crossref]

11. Mostafavi Abdolmaleky H, Zhou JR. Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases. Antioxidants (Basel). 2024 Aug 14;13(8):985. doi: 10.3390/antiox13080985. PMID: 39199231; PMCID: PMC11351922. [Google Scholar] [Crossref]

12. Savkovic SD. Gut microbes effects on host metabolic alterations in health and disease. Gut Microbes. 2020 May 3;11(3):249-252. doi: 10.1080/19490976.2020.1754097. PMID: 32543319; PMCID: PMC7524319. [Google Scholar] [Crossref]

13. Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016 Apr 20;8(1):42. doi: 10.1186/s13073-016-0303-2. PMID: 27098727; PMCID: PMC4839080. [Google Scholar] [Crossref]

14. Hur KY, Lee MS. Gut Microbiota and Metabolic Disorders. Diabetes Metab J. 2015 Jun;39(3):198-203. doi: 10.4093/dmj.2015.39.3.198. PMID: 26124989; PMCID: PMC4483604. [Google Scholar] [Crossref]

15. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995 Jun;125(6):1401-12. doi: 10.1093/jn/125.6.1401. PMID: 7782892. [Google Scholar] [Crossref]

16. Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, Trancassini M, Passariello C, Pantanella F, Schippa S. Rebuilding the Gut Microbiota Ecosystem. Int J Environ Res Public Health. 2018 Aug 7;15(8):1679. doi: 10.3390/ijerph15081679. PMID: 30087270; PMCID: PMC6121872. [Google Scholar] [Crossref]

17. Parracho HM, Burrowes BH, Enright MC, McConville ML, Harper DR. The role of regulated clinical trials in the development of bacteriophage therapeutics. J Mol Genet Med. 2012;6:279-86. doi: 10.4172/1747-0862.1000050. Epub 2012 Apr 23. PMID: 22872803; PMCID: PMC3410379. [Google Scholar] [Crossref]

18. Skalny AV, Aschner M, Lei XG, Gritsenko VA, Santamaria A, Alekseenko SI, Prakash NT, Chang JS, Sizova EA, Chao JCJ, Aaseth J, Tinkov AA. Gut Microbiota as a Mediator of Essential and Toxic Effects of Zinc in the Intestines and Other Tissues. Int J Mol Sci. 2021 Dec 3;22(23):13074. doi: 10.3390/ijms222313074. PMID: 34884881; PMCID: PMC8658153. [Google Scholar] [Crossref]

19. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020, GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. Doi: 10.3322/caac.21660. [Google Scholar] [Crossref]

20. 19..Levy M., Kolodziejczyk A.A., Thaiss C.A., Elinav E. Dysbiosis and the immune system. Nat. Rev. Immunol. 2017;17:219–232. Doi: 10.1038/nri.2017.7. [Google Scholar] [Crossref]

21. Petersen C., Round J.L. Defining dysbiosis and its influence on host immunity and disease. Cell. Microbiol. 2014;16:1024–1033. Doi: 10.1111/cmi.12308. [Google Scholar] [Crossref]

22. Brown K., Godovannyi A., Ma C., Zhang Y., Ahmadi-Vand Z., Dai C., Gorzelak M.A., Chan Y., Chan J.M., Lochner A., et al. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. ISME J. 2016;10:321–332. Doi: 10.1038/ismej.2015.114. [Google Scholar] [Crossref]

23. Koh A., Molinaro A., Ståhlman M., Khan M.T., Schmidt C., Mannerås-Holm L., Wu H., Carreras A., Jeong H., Olofsson L.E., et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175:947–961. Doi: 10.1016/j.cell.2018.09.055. [Google Scholar] [Crossref]

24. Sun L., Ma L., Ma Y., Zhang F., Zhao C., Nie Y. Insights into the role of gut microbiota in obesity: Pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell. 2018;9:397–403. Doi: 10.1007/s13238-018-0546-3. [Google Scholar] [Crossref]

25. Virtue A.T., McCright S.J., Wright J.M., Jimenez M.T., Mowel W.K., Kotzin J.J., Joannas L., Basavappa M.G., Spencer S.P., Clark M.L., et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci. Transl. Med. 2019;11:eaav1892. Doi: 10.1126/scitranslmed.aav1892. [Google Scholar] [Crossref]

26. Maini Rekdal V., Bess E.N., Bisanz J.E., Turnbaugh P.J., Balskus E.P. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019;364:eaau6323. Doi: 10.1126/science.aau6323. [Google Scholar] [Crossref]

27. Garrett W.S. Cancer and the microbiota. Science. 2015;348:80–86. Doi: 10.1126/science.aaa4972. [Google Scholar] [Crossref]

28. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. Doi: 10.1038/nrgastro.2014.66. [Google Scholar] [Crossref]

29. Mackowiak P.A. Recycling Metchnikoff: Probiotics, the intestinal microbiome and the quest for long life. Front. Public Health. 2013;1:52. Doi: 10.3389/fpubh.2013.00052. [Google Scholar] [Crossref]

30. Zhu Y., Michelle Luo T., Jobin C., Young H.A. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett. 2011;309:119–127. Doi: 10.1016/j.canlet.2011.06.004. [Google Scholar] [Crossref]

31. Shajib MS, Khan WI. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf) 2015;213:561–574. doi: 10.1111/apha.12430. [Google Scholar] [Crossref]

32. Silberbauer CJ, Surina-Baumgartner DM, Arnold M, Langhans W. Prandial lactate infusion inhibits spontaneous feeding in rats. Am J Physiol Regul Integr Comp Physiol. 2000;278:R646–R653. doi: 10.1152/ajpregu.2000.278.3.R646. [Google Scholar] [Crossref]

33. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4–7. [Google Scholar] [Crossref]

34. Lewis GF, Brubaker PL. The discovery of insulin revisited: lessons for the modern era. J Clin Invest. 2021 Jan 4;131(1):e142239. doi: 10.1172/JCI142239. PMID: 33393501; PMCID: PMC7773348. [Google Scholar] [Crossref]

35. Csajbók ÉA, Tamás G. Cerebral cortex: a target and source of insulin? Diabetologia. 2016 Aug;59(8):1609-15. doi: 10.1007/s00125-016-3996-2. Epub 2016 May 20. PMID: 27207082. [Google Scholar] [Crossref]

36. Cheng Z, Zhang L, Yang L, Chu H. The critical role of gut microbiota in obesity. Front Endocrinol (Lausanne). 2022 Oct 20;13:1025706. doi: 10.3389/fendo.2022.1025706. PMID: 36339448; PMCID: PMC9630587. [Google Scholar] [Crossref]

37. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021 Jul 7;27(25):3837-3850. doi: 10.3748/wjg.v27.i25.3837. PMID: 34321848; PMCID: PMC8291023. [Google Scholar] [Crossref]

38. Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. 2020 Apr 15;8(4):573. [Google Scholar] [Crossref]

39. doi: 10.3390/microorganisms8040573. PMID: 32326636; PMCID: PMC7232163. [Google Scholar] [Crossref]

40. Rodrigues VF, Elias-Oliveira J, Pereira ÍS, Pereira JA, Barbosa SC, Machado MSG, Carlos D. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol. 2022 Jul 7;13:934695. [Google Scholar] [Crossref]

41. doi: 10.3389/fimmu.2022.934695. PMID: 35874661; PMCID: PMC9300896. [Google Scholar] [Crossref]

• Quantitative Assessment of Serum C - Reactive Protein Levels among Smokers and Non Smokers
• Extraction and Characterization of Eco-Friendly Hair Dye from Agricultural Waste: A Study on Coconut Husk
• Intermittent Preventive Treatment among Pregnant Women Attending a Tertiary Healthcare Facility in Jos, North Central Nigeria: Adherence Patterns and Preliminary Assessment of Associated Factors
• Assessment Of Degradative Potentials Of Bacteria Isolated From Palm Oil-Polluted Site Using Spectrophotometric Method
• An Analysis of Machine and Deep Learning Insights on the Use of Artificial Intelligence in Oral and Maxillofacial Pathology